IL150361A0 - Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections - Google Patents
Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infectionsInfo
- Publication number
- IL150361A0 IL150361A0 IL15036100A IL15036100A IL150361A0 IL 150361 A0 IL150361 A0 IL 150361A0 IL 15036100 A IL15036100 A IL 15036100A IL 15036100 A IL15036100 A IL 15036100A IL 150361 A0 IL150361 A0 IL 150361A0
- Authority
- IL
- Israel
- Prior art keywords
- antibiotic
- composition
- prevention
- treatment
- resistant microorganism
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title abstract 4
- 230000003115 biocidal effect Effects 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 108010063045 Lactoferrin Proteins 0.000 abstract 3
- 102000010445 Lactoferrin Human genes 0.000 abstract 3
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 abstract 3
- 229940078795 lactoferrin Drugs 0.000 abstract 3
- 235000021242 lactoferrin Nutrition 0.000 abstract 3
- 101800004361 Lactoferricin-B Proteins 0.000 abstract 2
- CFFMZOZGXDAXHP-HOKBLYKWSA-N lactoferricin Chemical compound C([C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)N[C@H](C(N[C@H](C(=O)N1)[C@@H](C)O)=O)[C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CFFMZOZGXDAXHP-HOKBLYKWSA-N 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract 1
- 150000003952 β-lactams Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17257799P | 1999-12-20 | 1999-12-20 | |
| PCT/CA2000/001517 WO2001045732A2 (en) | 1999-12-20 | 2000-12-19 | Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL150361A0 true IL150361A0 (en) | 2002-12-01 |
Family
ID=22628296
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15036100A IL150361A0 (en) | 1999-12-20 | 2000-12-19 | Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| IL150361A IL150361A (en) | 1999-12-20 | 2002-06-20 | Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL150361A IL150361A (en) | 1999-12-20 | 2002-06-20 | Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20030134779A1 (de) |
| EP (1) | EP1246640B1 (de) |
| JP (1) | JP2003518072A (de) |
| AT (1) | ATE323506T1 (de) |
| AU (1) | AU782915B2 (de) |
| BR (1) | BR0016554A (de) |
| CA (1) | CA2394997A1 (de) |
| DE (1) | DE60027472T2 (de) |
| DK (1) | DK1246640T3 (de) |
| ES (1) | ES2262555T3 (de) |
| HK (1) | HK1050628B (de) |
| IL (2) | IL150361A0 (de) |
| MX (1) | MXPA02006143A (de) |
| PT (1) | PT1246640E (de) |
| WO (1) | WO2001045732A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786787B1 (fr) * | 1998-12-08 | 2002-04-19 | Proteus | Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques |
| CA2411944C (en) * | 2000-06-09 | 2010-12-14 | Baylor College Of Medicine | The combination of antimicrobial agents and bacterial interference to coat medical devices |
| DE202004006282U1 (de) * | 2004-04-19 | 2004-07-01 | Lohmann Animal Health Gmbh & Co. Kg | Vorrichtung für die Empfindlichkeitsprüfung bakterieller Infektionserreger und Impfstämme des Geflügels |
| JP5274248B2 (ja) | 2005-05-27 | 2013-08-28 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 酸化窒素治療及び医生物的応用のための酸化窒素放出粒子 |
| JP5087297B2 (ja) * | 2007-03-05 | 2012-12-05 | 森永乳業株式会社 | インターロイキン−１１産生促進剤 |
| NZ600269A (en) | 2009-05-20 | 2014-02-28 | Dec Int Nz Ltd | Delivery device for treatment of mastitis |
| JP5756096B2 (ja) * | 2009-06-12 | 2015-07-29 | ソックプラ−シアンセ エ ジェニー エス．ウ．セ． | グアニンリボスイッチ結合化合物及び抗生物質としてのその使用 |
| CN102695528B (zh) | 2009-08-21 | 2016-07-13 | 诺万公司 | 创伤敷料、其使用方法及其形成方法 |
| CA3062005C (en) | 2009-08-21 | 2022-02-15 | Novan, Inc. | Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof |
| US10273294B2 (en) | 2010-10-11 | 2019-04-30 | University Of Southern California | Compositions and methods for treating HIF-1α over-expressing cancers |
| US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
| EP2670417A4 (de) | 2011-01-31 | 2014-07-09 | Us Army | Verfahren und zusammensetzungen zur behandlung bakterieller infektionen mit eisenchelatoren |
| EP2681286B1 (de) | 2011-02-28 | 2018-08-15 | Novan, Inc. | Stickoxid-freisetzende s-nitrosothiol-modifizierte kieselsäureteilchen und verfahren zu ihrer herstellung |
| US20170296629A1 (en) * | 2014-10-08 | 2017-10-19 | Keio University | Inhibitor of extracellular trap formation in leukocyte |
| US12447166B2 (en) | 2016-02-25 | 2025-10-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| AU2017224113B2 (en) | 2016-02-25 | 2022-04-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| JP7458622B2 (ja) * | 2019-09-18 | 2024-04-01 | 学校法人東京農業大学 | 抗生物質耐性微生物の耐性を低下させる物質及び抗生物質耐性微生物の耐性を低下させる方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4304855A (en) * | 1977-05-05 | 1981-12-08 | The Upjohn Company | Allylic methyl-hydroxylated novobiocins |
| US5198419A (en) * | 1989-12-08 | 1993-03-30 | Immuno Japan Inc. | Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria |
| JPH0748274A (ja) * | 1991-06-26 | 1995-02-21 | Immuno Japan:Kk | 養殖漁業における病原微生物感染症の予防並びに治療用飼料の製法 |
| WO1993014640A1 (fr) * | 1992-01-23 | 1993-08-05 | Morinaga Milk Industry Co., Ltd. | Agent antibacterien et traitement d'articles au moyen de cet agent |
| FR2713240B1 (fr) * | 1993-12-02 | 1996-03-01 | Bio Merieux | Milieu nutritif pour la culture de microorganismes. |
| US5834424A (en) * | 1995-07-12 | 1998-11-10 | Gambit International Limited | Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus |
| US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| US6407091B1 (en) * | 1999-04-15 | 2002-06-18 | Research Corporation Technologies, Inc. | β-lactamase inhibiting compounds |
-
2000
- 2000-12-19 AU AU23349/01A patent/AU782915B2/en not_active Ceased
- 2000-12-19 CA CA002394997A patent/CA2394997A1/en not_active Abandoned
- 2000-12-19 PT PT00986923T patent/PT1246640E/pt unknown
- 2000-12-19 US US10/168,257 patent/US20030134779A1/en not_active Abandoned
- 2000-12-19 HK HK03101482.0A patent/HK1050628B/en not_active IP Right Cessation
- 2000-12-19 IL IL15036100A patent/IL150361A0/xx active IP Right Grant
- 2000-12-19 BR BR0016554-9A patent/BR0016554A/pt not_active Application Discontinuation
- 2000-12-19 JP JP2001546671A patent/JP2003518072A/ja active Pending
- 2000-12-19 DE DE60027472T patent/DE60027472T2/de not_active Expired - Lifetime
- 2000-12-19 WO PCT/CA2000/001517 patent/WO2001045732A2/en not_active Ceased
- 2000-12-19 ES ES00986923T patent/ES2262555T3/es not_active Expired - Lifetime
- 2000-12-19 DK DK00986923T patent/DK1246640T3/da active
- 2000-12-19 MX MXPA02006143A patent/MXPA02006143A/es active IP Right Grant
- 2000-12-19 AT AT00986923T patent/ATE323506T1/de not_active IP Right Cessation
- 2000-12-19 EP EP00986923A patent/EP1246640B1/de not_active Expired - Lifetime
-
2002
- 2002-06-20 IL IL150361A patent/IL150361A/en not_active IP Right Cessation
-
2005
- 2005-11-23 US US11/287,026 patent/US20060142183A1/en not_active Abandoned
-
2007
- 2007-10-31 US US11/981,316 patent/US20080207491A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60027472T2 (de) | 2006-12-07 |
| MXPA02006143A (es) | 2004-08-23 |
| AU2334901A (en) | 2001-07-03 |
| DK1246640T3 (da) | 2006-08-21 |
| IL150361A (en) | 2008-04-13 |
| ES2262555T3 (es) | 2006-12-01 |
| WO2001045732A3 (en) | 2001-12-06 |
| US20080207491A1 (en) | 2008-08-28 |
| PT1246640E (pt) | 2006-07-31 |
| ATE323506T1 (de) | 2006-05-15 |
| AU782915B2 (en) | 2005-09-08 |
| EP1246640A2 (de) | 2002-10-09 |
| CA2394997A1 (en) | 2001-06-28 |
| HK1050628A1 (en) | 2003-07-04 |
| JP2003518072A (ja) | 2003-06-03 |
| WO2001045732A2 (en) | 2001-06-28 |
| HK1050628B (en) | 2006-10-20 |
| US20060142183A1 (en) | 2006-06-29 |
| EP1246640B1 (de) | 2006-04-19 |
| BR0016554A (pt) | 2003-02-11 |
| DE60027472D1 (de) | 2006-05-24 |
| US20030134779A1 (en) | 2003-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL150361A0 (en) | Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections | |
| ATE219684T1 (de) | Anti gram positive bakterielle verfahren und mittel | |
| WO2001051066A3 (en) | Reduction in bacterial colonization by administering bacteriophage compositions | |
| WO2000010582A8 (en) | Probiotic, lactic acid-producing bacteria and uses thereof | |
| NZ506058A (en) | Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof | |
| NZ718955A (en) | Compositions comprising povidone-iodine | |
| WO2005030186A3 (en) | Method for attenuating virulence of microbial pathogens and for inhibiting microbial biofilm formation | |
| NO991548D0 (no) | Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer | |
| MX2010004407A (es) | Antibioticos de carbacefem beta-lactama. | |
| ZA202309204B (en) | Lactivicin compounds, their preparation and use as antibacterial agents | |
| Anwar et al. | Effective use of antibiotics in the treatment of biofilm-associated infections. | |
| WO2007024628A3 (en) | Ply-gbs mutant lysins | |
| CA2534013A1 (en) | Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection | |
| TW200716162A (en) | Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria | |
| DK1618106T3 (da) | Carbacephem beta-lactam antibiotika | |
| WO2004060272A3 (en) | Delivery of peroxide-generating enzymes to the vaginal tract | |
| IL150675A0 (en) | The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections | |
| DE60214889D1 (en) | Sucroseoctasulphat silber saltz | |
| Steenvoorde et al. | Maggot debridement therapy in necrotizing fasciitis reduces the number of surgical debridements | |
| DK1439840T3 (da) | Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf | |
| WO2005086669A3 (en) | Hydrogenase deficient bacterial strains | |
| PL1687014T3 (pl) | Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi | |
| WO2001068675A3 (en) | Treatment of rosacea | |
| Ambrožić et al. | The effect of occlusive hydrocolloid dressing on microbial flora of chronic leg ulcers | |
| Kim et al. | Patterns of antimicrobial susceptibility of the causative bacteria of urinary tract infections in recent years in an island region |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |